OA09247A - "Procédé stéréospécifique pour la préparation des énantiomères de la furo (3,4-c) pyridine, composés ainsi obtenus et compositions thérapeutiques à base de ces composés". - Google Patents
"Procédé stéréospécifique pour la préparation des énantiomères de la furo (3,4-c) pyridine, composés ainsi obtenus et compositions thérapeutiques à base de ces composés".Info
- Publication number
- OA09247A OA09247A OA59691A OA59691A OA09247A OA 09247 A OA09247 A OA 09247A OA 59691 A OA59691 A OA 59691A OA 59691 A OA59691 A OA 59691A OA 09247 A OA09247 A OA 09247A
- Authority
- OA
- OAPI
- Prior art keywords
- compounds
- furo
- enantiomers
- pyridine
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888808001A GB8808001D0 (en) | 1988-04-06 | 1988-04-06 | Stereospecific preparative process for furol(3,4-c)pyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
OA09247A true OA09247A (fr) | 1992-06-30 |
Family
ID=10634633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA59691A OA09247A (fr) | 1988-04-06 | 1989-12-10 | "Procédé stéréospécifique pour la préparation des énantiomères de la furo (3,4-c) pyridine, composés ainsi obtenus et compositions thérapeutiques à base de ces composés". |
Country Status (28)
Country | Link |
---|---|
US (1) | US5026855A (lt) |
EP (1) | EP0337858B1 (lt) |
JP (1) | JP2680456B2 (lt) |
KR (1) | KR970005308B1 (lt) |
AT (1) | AT397093B (lt) |
AU (1) | AU616753B2 (lt) |
BE (1) | BE1003843A4 (lt) |
CA (1) | CA1338475C (lt) |
CH (1) | CH680000A5 (lt) |
DK (1) | DK167020B1 (lt) |
DZ (1) | DZ1335A1 (lt) |
ES (1) | ES2057159T3 (lt) |
FI (1) | FI93116C (lt) |
FR (2) | FR2629821B1 (lt) |
GB (2) | GB8808001D0 (lt) |
IE (1) | IE61915B1 (lt) |
IN (1) | IN172987B (lt) |
MA (1) | MA21529A1 (lt) |
MY (1) | MY104424A (lt) |
NL (1) | NL8920307A (lt) |
NZ (1) | NZ228614A (lt) |
OA (1) | OA09247A (lt) |
PT (1) | PT90210B (lt) |
SE (1) | SE509130C2 (lt) |
SG (1) | SG40492G (lt) |
TN (1) | TNSN89043A1 (lt) |
WO (1) | WO1989009772A1 (lt) |
ZA (1) | ZA892477B (lt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8808001D0 (en) * | 1988-04-06 | 1988-05-05 | Scras | Stereospecific preparative process for furol(3,4-c)pyridine derivatives |
GB8907480D0 (en) * | 1989-04-03 | 1989-05-17 | Scaras Societe De Conseils De | Separation of insomers of furo(3,4-c)pyridine derivatives |
GB8917168D0 (en) * | 1989-07-27 | 1989-09-13 | Scras | Asymmetric synthesis of furo(3,4-c)pyridine derivatives |
US5130252A (en) * | 1990-05-14 | 1992-07-14 | Synthetech, Inc. | Resolution of furopyridine enantiomers and synthetic precursors thereof |
US20050113314A1 (en) * | 2003-08-29 | 2005-05-26 | Fong Benson M. | Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome |
US20060089374A1 (en) * | 2003-07-17 | 2006-04-27 | Glenn Cornett | Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease |
US20060154959A1 (en) * | 2005-01-13 | 2006-07-13 | Navitas Pharma | Combination therapies of cicletanine and carvedilol |
US20080096915A1 (en) * | 2005-01-13 | 2008-04-24 | Greenberg Traurig LLP | Compositions for the treatment of metabolic disorders |
US20070141174A1 (en) * | 2005-01-13 | 2007-06-21 | Navitas Pharma, Inc. | Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension |
US20070105817A1 (en) * | 2005-11-09 | 2007-05-10 | Jim Page | Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension |
CA2674367A1 (en) * | 2007-01-03 | 2008-07-17 | Glenn V. Cornett | Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders |
AR073259A1 (es) * | 2008-07-29 | 2010-10-28 | Merck & Co Inc | Derivados de furosemida utiles como diureticos |
US8377911B2 (en) | 2009-10-09 | 2013-02-19 | Merck Sharp & Dohme Corp. | Diuretics |
WO2015103445A1 (en) * | 2013-12-31 | 2015-07-09 | Rockey Don C | Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4244951A (en) * | 1979-05-16 | 1981-01-13 | Pfizer Inc. | Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide |
IN156817B (lt) * | 1981-02-10 | 1985-11-09 | Scras | |
IN160104B (lt) * | 1983-04-05 | 1987-06-27 | Scras | |
GB2137618B (en) * | 1983-04-05 | 1986-05-08 | Scras | Furo-(3,4-c)-pyridine derivatives |
ZA842029B (en) * | 1983-04-05 | 1984-10-31 | Scras | Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same |
US4735950A (en) * | 1983-04-05 | 1988-04-05 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) | Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same |
GB8327817D0 (en) * | 1983-10-18 | 1983-11-16 | Scras | 4-halo-furo-(3 4-c)-pyridine derivatives |
GB8330517D0 (en) * | 1983-11-16 | 1983-12-21 | Scras | 6-vinyl-furo-(3,4-c)pyridine derivatives |
GB8330658D0 (en) * | 1983-11-17 | 1983-12-29 | Scras | 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives |
GB8402740D0 (en) * | 1984-02-02 | 1984-03-07 | Scras | Furo-(3 4-c)-pyridine derivatives |
GB8414559D0 (en) * | 1984-06-07 | 1984-07-11 | Scras | Pyridine derivatives |
GB8422029D0 (en) * | 1984-08-31 | 1984-10-03 | Scras | 6-substituted-furo-(3 4-c)-pyridine derivatives |
GB8422379D0 (en) * | 1984-09-05 | 1984-10-10 | Scras | Derivatives |
GB8427218D0 (en) * | 1984-10-27 | 1984-12-05 | Scras | Pyridine derivatives |
DE3519693A1 (de) * | 1985-06-01 | 1987-01-02 | Basf Ag | Pyridin-derivate, ihre herstellung und verwendung |
GB8808001D0 (en) * | 1988-04-06 | 1988-05-05 | Scras | Stereospecific preparative process for furol(3,4-c)pyridine derivatives |
GB8907480D0 (en) * | 1989-04-03 | 1989-05-17 | Scaras Societe De Conseils De | Separation of insomers of furo(3,4-c)pyridine derivatives |
-
1988
- 1988-04-06 GB GB888808001A patent/GB8808001D0/en active Pending
-
1989
- 1989-04-01 DZ DZ890060A patent/DZ1335A1/fr active
- 1989-04-04 IN IN312DE1989 patent/IN172987B/en unknown
- 1989-04-04 ZA ZA892477A patent/ZA892477B/xx unknown
- 1989-04-04 MA MA21776A patent/MA21529A1/fr unknown
- 1989-04-05 NZ NZ228614A patent/NZ228614A/en unknown
- 1989-04-05 IE IE107689A patent/IE61915B1/en not_active IP Right Cessation
- 1989-04-05 CA CA000595814A patent/CA1338475C/en not_active Expired - Fee Related
- 1989-04-05 BE BE8900379A patent/BE1003843A4/fr not_active IP Right Cessation
- 1989-04-06 EP EP89400956A patent/EP0337858B1/fr not_active Expired - Lifetime
- 1989-04-06 GB GB8927509A patent/GB2235194B/en not_active Expired - Fee Related
- 1989-04-06 KR KR1019890702267A patent/KR970005308B1/ko not_active IP Right Cessation
- 1989-04-06 TN TNTNSN89043A patent/TNSN89043A1/fr unknown
- 1989-04-06 ES ES89400956T patent/ES2057159T3/es not_active Expired - Lifetime
- 1989-04-06 AT AT0900589A patent/AT397093B/de not_active IP Right Cessation
- 1989-04-06 AU AU34190/89A patent/AU616753B2/en not_active Ceased
- 1989-04-06 NL NL8920307A patent/NL8920307A/nl active Search and Examination
- 1989-04-06 WO PCT/FR1989/000157 patent/WO1989009772A1/fr active IP Right Grant
- 1989-04-06 JP JP1504150A patent/JP2680456B2/ja not_active Expired - Fee Related
- 1989-04-06 FR FR8904540A patent/FR2629821B1/fr not_active Expired - Lifetime
- 1989-04-06 FR FR8904539A patent/FR2629820B1/fr not_active Expired - Fee Related
- 1989-04-06 CH CH4339/89A patent/CH680000A5/fr not_active IP Right Cessation
- 1989-04-06 PT PT90210A patent/PT90210B/pt not_active IP Right Cessation
- 1989-04-06 MY MYPI89000437A patent/MY104424A/en unknown
- 1989-11-28 US US07/449,946 patent/US5026855A/en not_active Expired - Lifetime
- 1989-12-05 SE SE8904104A patent/SE509130C2/sv not_active IP Right Cessation
- 1989-12-05 FI FI895826A patent/FI93116C/fi not_active IP Right Cessation
- 1989-12-05 DK DK611689A patent/DK167020B1/da not_active IP Right Cessation
- 1989-12-10 OA OA59691A patent/OA09247A/xx unknown
-
1992
- 1992-04-14 SG SG404/92A patent/SG40492G/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA09247A (fr) | "Procédé stéréospécifique pour la préparation des énantiomères de la furo (3,4-c) pyridine, composés ainsi obtenus et compositions thérapeutiques à base de ces composés". | |
OA07947A (fr) | Nouveaux dérivés de la furo-(3,4-c)-pyridine substitués en position 6, un procédé pour leur préparation et compositions thérapeutiques à base de ces dérivés. | |
OA09387A (fr) | "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues". | |
DZ712A1 (fr) | Nouveaux dérivés de 2-2 iminobisethanol utiles comme médecaments, intermédiaires pour leur préparation et procédés pour la préparation de ces dérivés et intermédiaires. | |
OA07864A (fr) | Nouveaux dérivés de la vinyl-6 furo-(3,4-c) -pyridine leur préparation et compositions pharmaceutiques à base de ces composés. | |
OA08235A (fr) | Composés intermediaires de carbapénem et leur procédé de préparation. | |
DZ1758A1 (fr) | Procédé pour la préparation d'aryl-piperidine carbinols. | |
DZ1414A1 (fr) | Dérivés de la thiéno-triazolo-diazépine, ainsi qu'un procédé de préparation desdits composés. | |
OA07984A (fr) | Procédé stéréocontrolé de préparation d'acetoxyazetidione. | |
OA07674A (fr) | Procédé de préparation de dérivés de carbapénem, nouveaux intermédiaires de synthèse et préparation de ces intermédiaires. | |
DZ1407A1 (fr) | Dérivés d-substitués des n,n'-ditriméthoxybenzoylepipérazine ainsi que leur procédé de préparation. | |
OA09201A (fr) | "Dérivés sulfonyles de la thiéno-triazolo-diazépine, un procédé pour leur préparation et des compositions thérapeutiques en contenant". | |
OA07840A (fr) | Dérivés de la chloro-4-furo-(3,4-c)-pyridine, leur procédé de préparation et compositions thérapeutiques à base de ces dérivés. | |
OA08172A (fr) | Nouveaux dérivés de la thiénopyridine, un procédé pour leur préparation et compositions thérapeutiques à base de ces dérivés. | |
OA08125A (fr) | Nouveaux dérivés de la pyridine, un procédé pour leur préparation et compositions thérapeutiques à base de ces dérivés. | |
FR2709490B3 (fr) | Procédé perfectionné pour la préparation de l'astaxanthine. | |
OA06690A (fr) | Composés d'amino-thiadiazolyle, procédé pour leur préparation. | |
FR2623501B1 (fr) | Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant | |
OA08128A (fr) | Nouveaux dérivés de la phénéthylaminoal-6 furo-(3,4-c)-pyridine, leur préparation et compositions thérapeutiques à base de ceux-ci. | |
OA08416A (fr) | Nouveaux dérivés du catéchol, un procédé pour leur préparation et compositions thérapeutiques à base de ces dérivés. | |
OA09903A (fr) | Dérivés de la Benzofuranylimidazol, leur procédé de préparation ainsi qu'une composition thérapeutique les contenant. | |
HK47392A (en) | Stereospecific process for the preparation of furo(3,4-c)pyridine enantiomers,compounds thus obtained and therapeutical compositions thereof | |
FR2712594B1 (fr) | Procédé de préparation de l'oenotheine B à partir d'Epilobium Parviflorum. | |
OA07416A (fr) | Nouvelles argiles modifiées, leur procédé de préparation et compositions thérapeutiques à base de ces argiles. | |
BE1002101A4 (fr) | Procede pour la preparation de derives d'as-triazine condenses et composes obtenus. |